Martin SJ - Search Results

1

The use of fluoroquinolones in the treatment of skin infections.

Martin SJ, Zeigler DG. Martin SJ, et al. Expert Opin Pharmacother. 2004 Feb;5(2):237-46. doi: 10.1517/14656566.5.2.237. Expert Opin Pharmacother. 2004. PMID: 14996621 Review.

2

Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections.

Martin SJ, Sahloff EG, Close SJ. Martin SJ, et al. Expert Opin Pharmacother. 2002 Sep;3(9):1251-66. doi: 10.1517/14656566.3.9.1251. Expert Opin Pharmacother. 2002. PMID: 12186618 Review.

3

Levofloxacin and sparfloxacin: new quinolone antibiotics.

Martin SJ, Meyer JM, Chuck SK, Jung R, Messick CR, Pendland SL. Martin SJ, et al. Ann Pharmacother. 1998 Mar;32(3):320-36. doi: 10.1345/aph.17178. Ann Pharmacother. 1998. PMID: 9533064 Review.

4

A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.

Martin SJ, Jung R, Garvin CG. Martin SJ, et al. Drug Saf. 2001;24(3):199-222. doi: 10.2165/00002018-200124030-00004. Drug Saf. 2001. PMID: 11347723 Review.

5

Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.

Close SJ, McBurney CR, Garvin CG, Chen DC, Martin SJ. Close SJ, et al. Among authors: martin sj. Pharmacotherapy. 2002 Aug;22(8):983-9. doi: 10.1592/phco.22.12.983.33599. Pharmacotherapy. 2002. PMID: 12173801 Free article.

6

Infectious diseases in the critically ill patients.

Martin SJ, Yost RJ. Martin SJ, et al. J Pharm Pract. 2011 Feb;24(1):35-43. doi: 10.1177/0897190010388906. J Pharm Pract. 2011. PMID: 21507873 Review.

7

Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila.

Martin SJ, Pendland SL. Martin SJ, et al. J Antimicrob Chemother. 1998 Jun;41(6):643-8. doi: 10.1093/jac/41.6.643. J Antimicrob Chemother. 1998. PMID: 9687103

8

The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.

Martin SJ, Garvin CG, McBurney CR, Sahloff EG. Martin SJ, et al. J Antimicrob Chemother. 2001 May;47(5):581-7. doi: 10.1093/jac/47.5.581. J Antimicrob Chemother. 2001. PMID: 11328768

9

Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.

Pendland SL, Martin SJ, Chen C, Schreckenberger PC, Danziger LH. Pendland SL, et al. Among authors: martin sj. J Clin Microbiol. 1997 Nov;35(11):3004-6. doi: 10.1128/jcm.35.11.3004-3006.1997. J Clin Microbiol. 1997. PMID: 9350781 Free PMC article.

10

Pharmacokinetics and clinical use of drotrecogin alfa (activated) in patients with severe sepsis.

Olsen KM, Martin SJ. Olsen KM, et al. Among authors: martin sj. Pharmacotherapy. 2002 Dec;22(12 Pt 2):196S-205S. doi: 10.1592/phco.22.18.196s.33708. Pharmacotherapy. 2002. PMID: 12492226 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

562 results

Search Page

Filters